Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis

Nephron - Experimental Nephrology

Volumn 106, Issue 3, 2007, Pages

  Kudo, Yoshihiro ^a   Kakinuma, Yoshihiko ^a   Iguchi, Mitsuko ^a   Sato, Takayuki ^a   Sugiura, Tetsuro ^a   Furihata, Mutsuo ^a   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Glomerulonephritis; Renal protection; Von Hippel Lindau protein

Indexed keywords

SNAKE VENOM; THROMBIN; VON HIPPEL LINDAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY; KIDNEY INJURY; KIDNEY TUBULE; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CELL LINE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; PODOCYTES; RATS; RATS, WISTAR; SNAKE VENOMS; THROMBIN; TRIMERESURUS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 34347405968     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103022     Document Type: Article

References (29)

1. Kudo Y, Kakinuma Y, Mori Y, Morimoto N, Karashima T, Furihata M, Sato T, Shuin T, Sugiura T: Hypoxia-inducible factor-1α is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2005;100:e95-e103.
2. Faulkner JL, Szcykalski LM, Springer F, Barnes JL: Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005;167:1193-1205.
3. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-275.
4. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP: Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 2002;296:1886-1889.
5. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
6. Ruggenenti P: Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Semin Nephrol 2004;24:158-167.
7. Kitamura H, Sugisaki Y, Yamanaka N: Endothelial regeneration during the repair process following Habu-snake venom induced glomerular injury. Virchows Arch 1995;427:195-204.
8. Barnes JL, Mitchell RJ, Kanalas JJ, Barnes VL: Differential expression of thrombospondin and cellular fibronectin during remodeling in proliferative glomerulonephritis. J Histochem Cytochem 1999;47:533-544.
9. Barnes JL: In situ hybridization in the study of remodeling in proliferative glomerulonephritis. Toxicol Pathol 1998;26:43-51.
10. Turcotte S, Desrosiers RR, Brand G, Beliveau R: von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation. Int J Cancer 2004;112:777-786.
11. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-143.
12. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, Sato T: Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1α. FEBS Lett 2005;579:2111-2118.
13. Jones NM, Bergeron M: Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 2001;21:1105-1114.
14. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003;14:1825-1832.
15. Yang YT, Ju TC, Yang DI: Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. Neurochem 2005;93:513-525.
16. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE: HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-724.
17. Page EL, Robitaille GA, Pouyssegur J, Richard DE: Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem 2002;277:48403-48409.
18. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 2001;89:47-54.
19. He CJ, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD: Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol 1991;146:131-140.
20. Gordon EA, Fenton JW 2nd, Carney DH: Thrombin-receptor occupancy initiates a transient increase in cAMP levels in mitogenically responsive hamster (NIL) fibroblasts. Ann NY Acad Sci 1986;485:249-263.
21. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000;191:455-462.
22. Moake JL: Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
23. Keller K, Daniel C, Schocklmann H, Endlich K-H, Kerjaschki D, Johnson RJ, Hugo C: Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy. Nephrol Dial Transplant 2006;21:2724-2735.
24. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE: Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006;17:724-735.
25. Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ: Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005;288:F48-F57.
26. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003;284:F1263-F1273.
27. Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005;54:1626-1634.
28. Takahashi H, Hattori S, Iwamatsu A, Takizawa H, Shibuya M: A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J Biol Chem 2004;279:46304-46314.
29. Barnes JL, Mitchell RJ, Torres ES: Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat. J Histochem Cytochem 1995;43:895-905.